Literature DB >> 7892449

Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results.

E Leen1, W J Angerson, H Wotherspoon, B Moule, T G Cook, C S McArdle.   

Abstract

PURPOSE: To assess the value of the Doppler perfusion index (DPI = the ratio of hepatic arterial to total liver blood flow) as measured with duplex and color Doppler sonography (DCDS) in comparison with computed tomography (CT), conventional ultrasound (US), and laparotomy for the detection of liver metastases in patients with colorectal cancer.
MATERIALS AND METHODS: DCDS measurement of the DPI and CT, US, and laparotomy were performed in 161 consecutive colorectal cancer patients. Patients who underwent an apparently curative resection were followed up at 3-month intervals with US and at annual CT.
RESULTS: Fifty-six patients had histologically proved liver metastases at initial examination. Liver metastases were detected with DPI, CT, US, and laparotomy in 56, 45, 27, and 36 patients, respectively. After a 1-year follow-up, 23 patients had developed liver metastases, all of which were predicted on the basis of an abnormal DPI value.
CONCLUSION: Results suggest that DCDS measurement of the DPI is the most sensitive technique in detection of colorectal liver metastases. All studies should attempt to define normal liver on the basis of follow-up results rather than those of laparotomy.

Entities:  

Mesh:

Year:  1995        PMID: 7892449     DOI: 10.1148/radiology.195.1.7892449

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

Review 1.  Potential use of Doppler perfusion index in detection of occult liver metastases from colorectal cancer.

Authors:  Mario Kopljar; Leonardo Patrlj; Zeljko Bušić; Marijan Kolovrat; Mislav Rakić; Robert Kliček; Marcel Zidak; Igor Stipančić
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

Review 2.  Natural history of liver metastases from colorectal carcinoma.

Authors:  J Norstein; W Silen
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

3.  Changes in hepatic perfusion assessed by dynamic contrast enhanced MRI, associated with morphologic evaluation, in patients with liver metastases from colorectal cancer treated with first-line chemotherapy.

Authors:  Marco Tampellini; Dario Gned; Chiara Baratelli; Maria Pia Brizzi; Azzurra Ottone; Irene Alabiso; Chiara Bertaggia; Massimo Di Maio; Giorgio Vittorio Scagliotti; Andrea Veltri
Journal:  Radiol Med       Date:  2016-09-06       Impact factor: 3.469

Review 4.  Conventional radiological strategy of common gastrointestinal neoplasms.

Authors:  Yi-Zhuo Li; Pei-Hong Wu
Journal:  World J Radiol       Date:  2015-01-28

5.  Does the presence of distant and local malignancy alter parenchymal perfusion in apparently disease-free areas of the liver?

Authors:  Y Tsushima; M J Blomley; H Yokoyama; S Kusano; K Endo
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

Review 6.  Monitoring tumour response.

Authors:  J E Husband
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 7.  Imaging of metastases to the liver.

Authors:  A E Mahfouz; B Hamm; D Mathieu
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

8.  Hepatic blood flow changes in chronic hepatitis C measured by duplex Doppler color sonography: relationship to histological features.

Authors:  K M Walsh; E Leen; R N MacSween; A J Morris
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

9.  Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study.

Authors:  Vicky Goh; Steve Halligan; David M Wellsted; Clive I Bartram
Journal:  Eur Radiol       Date:  2008-08-15       Impact factor: 5.315

10.  Relationship between CT volumetric measurements and Doppler perfusion indices in gastrointestinal liver metastasis.

Authors:  Amir Reza Radmard; Alireza Abrishami; Ali Gholamrezanezhad; Shadi Kolahdoozan; Nahid Sedighi; Amir Pejman Hashemi Taheri
Journal:  Radiol Med       Date:  2014-06-11       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.